Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
2006-12-25
pubmed:abstractText
Bone sialoprotein (BSP) is an acidic glycoprotein that plays an important role in cancer cell growth, migration and invasion. The expression, localization and possible function of BSP in chronic pancreatitis (CP) and pancreatic ductal adenocarcinoma (PDAC) were analyzed by QRT-PCR, laser capture microdissection, DNA microarray analysis, immunoblotting, radioimmunoassays and immunohistochemistry as well as cell growth, invasion, scattering, and adhesion assays. BSP mRNA was detected in 40.7% of normal, in 80% of CP and in 86.4% of PDAC samples. The median BSP mRNA levels were 6.1 and 0.9copies/microl cDNA in PDAC and CP tissues, respectively, and zero copies/microl cDNA in normal pancreatic tissues. BSP was weakly present in the cytoplasm of islet cells and ductal cells in 20% of normal pancreatic tissues. BSP was localized in the tubular complexes of both CP and PDAC, as well as in pancreatic cancer cells. Five out of 8 pancreatic cancer cell lines expressed BSP mRNA. Recombinant BSP (rBSP) inhibited Capan-1 and SU8686 pancreatic cancer cell growth, with a maximal effect of -46.4+/-12.0% in Capan-1 cells and -45.7+/-14.5% in SU8686 cells. rBSP decreased the invasion of SU8686 cells by -59.1+/-11.2% and of Capan-1 cells by -13.3+/-3.8% (P<0.05), whereas it did not affect scattering or adhesion of both cell lines. In conclusion, endogenous BSP expression levels in pancreatic cancer cells and low to absent BSP expression in the surrounding stromal tissue elements may indirectly act to enhance the proliferation and invasion of pancreatic cancer cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0304-3835
pubmed:author
pubmed:issnType
Print
pubmed:day
8
pubmed:volume
245
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
171-83
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:16488077-Carcinoma, Pancreatic Ductal, pubmed-meshheading:16488077-Cell Adhesion, pubmed-meshheading:16488077-Cell Line, Tumor, pubmed-meshheading:16488077-Cell Movement, pubmed-meshheading:16488077-Cell Proliferation, pubmed-meshheading:16488077-Cell Survival, pubmed-meshheading:16488077-DNA Methylation, pubmed-meshheading:16488077-Dose-Response Relationship, Drug, pubmed-meshheading:16488077-Gene Expression Regulation, Neoplastic, pubmed-meshheading:16488077-Humans, pubmed-meshheading:16488077-Immunoblotting, pubmed-meshheading:16488077-Immunohistochemistry, pubmed-meshheading:16488077-Integrin-Binding Sialoprotein, pubmed-meshheading:16488077-Neoplasm Invasiveness, pubmed-meshheading:16488077-Neoplasm Metastasis, pubmed-meshheading:16488077-Pancreatic Neoplasms, pubmed-meshheading:16488077-Promoter Regions, Genetic, pubmed-meshheading:16488077-RNA, Messenger, pubmed-meshheading:16488077-Radioimmunoassay, pubmed-meshheading:16488077-Recombinant Proteins, pubmed-meshheading:16488077-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16488077-Sialoglycoproteins
pubmed:year
2007
pubmed:articleTitle
Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
pubmed:affiliation
Department of General Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't